Summer Travel Season Backdrop: Ebola, Mpox, and Flesh

As millions of Americans pack bags for summer vacations, public health officials are tracking an unsettling convergence of disease threats that could reshape travel plans and strain healthcare systems. An Ebola outbreak in Central Africa is growing faster than expected, a localized mpox surge has appeared in Boston, flesh-eating bacterial infections are rising in Florida waters, and a hantavirus cluster linked to a cruise ship has killed multiple passengers across several countries.

Each of these threats differs in scale, geography, and risk level. But together, they illustrate a pattern that has become increasingly clear since the COVID-19 pandemic: in a world of mass international travel, localized outbreaks do not stay localized for long.

The Ebola situation is the most alarming from a global health perspective. The current outbreak in the Democratic Republic of the Congo, driven by the rare Bundibugyo strain, has produced approximately 900 suspected cases and 220 suspected deaths, according to World Health Organization assessments. Former CDC Director Robert Redfield has warned that this could become the second largest Ebola outbreak in history, a sobering projection given that the largest, the 2014-2016 West Africa epidemic, killed more than 11,000 people and infected nearly 29,000.

The Bundibugyo strain is particularly concerning because there are currently no approved treatments or vaccines specifically designed for it. The rVSV-ZEBOV vaccine, which proved effective during the 2018-2020 DRC outbreak, targets the Zaire strain, a different variant. While some cross-protection may exist, the scientific community has limited data on how well existing countermeasures work against Bundibugyo. The WHO has five confirmed recoveries using experimental treatments, but these early results do not constitute a proven protocol.

The logistical challenges are immense. Eastern DRC is a conflict zone with limited healthcare infrastructure, poor road networks, and ongoing armed group activity that impedes contact tracing and isolation efforts. The same conditions that made previous Ebola outbreaks difficult to contain, armed conflict, community distrust, and inadequate medical facilities, are present in full force.

The mpox situation in Boston presents a different kind of concern. While national mpox case counts have declined from their 2022 peak, the virus has proven it can reemerge in dense urban environments, particularly during summer when social events and travel increase person-to-person contact. Boston's localized surge suggests that mpox has not been eliminated from the United States but is instead persisting in networks where vaccination rates remain below the threshold needed for community protection.

Florida's rising Vibrio infections are perhaps the most directly relevant threat to American summer travelers. Vibrio vulnificus, often called flesh-eating bacteria, thrives in warm coastal waters. As ocean temperatures rise, the bacteria's habitat expands northward, and cases that were once rare in places like the Chesapeake Bay are becoming more common. Infections typically occur when open wounds come into contact with contaminated water or when raw shellfish are consumed. The mortality rate for Vibrio vulnificus bloodstream infections is approximately 50 percent, making it one of the deadliest foodborne pathogens in the United States.

Florida is particularly vulnerable because its warm coastal waters, extensive shoreline, and massive summer tourism create the perfect conditions for exposure. The state health department has already issued advisories, and emergency room physicians in coastal areas are being alerted to consider Vibrio in patients presenting with rapidly progressing skin infections after water contact.

The cruise ship hantavirus cluster adds another dimension. Multiple passengers aboard the MV Hondius have been sickened and several have died from hantavirus, a rodent-borne disease that can cause severe respiratory and renal failure. Cruise ships, with their enclosed environments and international passenger mixes, are ideal incubators for disease transmission. The incubation period for hantavirus can extend to several weeks, meaning infected passengers may not show symptoms until long after they have disembarked and dispersed to their home countries.

For travelers, the practical risks remain low for any individual trip. Ebola transmission requires direct contact with bodily fluids of an infected person, which is unlikely for typical tourists. Mpox requires close physical contact. Hantavirus, while serious, is rare. But Vibrio infections are a genuine concern for anyone swimming in warm coastal waters with open cuts or consuming raw oysters, and the risk is rising measurably with water temperatures.

What This Means For You: If you are traveling this summer, the single most actionable step is to avoid swimming in warm coastal waters if you have any open cuts, scrapes, or wounds, and to be cautious with raw shellfish, particularly oysters, from the Gulf Coast. This is not theoretical advice; Vibrio infections are increasing and they can be lethal. For mpox awareness, check your vaccination status if you are in a higher-risk group, and be aware that cases are appearing in urban areas again. For international travel, stay informed about Ebola screening protocols, which may change rapidly if the DRC outbreak expands. The CDC's travel health notices are updated frequently and are the best real-time resource. The broader lesson from this convergence of threats is that public health infrastructure matters more than most people realize until it is tested. The systems that detect, track, and respond to outbreaks are the same systems that have been chronically underfunded for decades. That is worth remembering the next time budget cuts target public health agencies.